Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Voisin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annales De Biologie Clinique|November 16, 2021
A typical babesiosis in an immunocompetent patientOlivier Voisin, Lorra Monpierre, Erwan Le Lorc'h, et al.
Mayo Clinic Proceedings|August 6, 2020
Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 InfectionOlivier Voisin, Erwan le Lorc'h, Annabelle Mahé, et al.
Infectious Diseases in Clinical Practice (Baltimore, Md.)|June 30, 2021
Disseminated Herpes Zoster During COVID-19Olivier Voisin, Nina Deluca, Annabelle Mahé, et al.
The Lancet. Rheumatology|August 25, 2020
Anakinra for severe forms of COVID-19: a cohort studyThomas Huet, Hélène Beaussier, Olivier Voisin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 16, 2021
No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot studyBenoît Pilmis, Olivier Jiang, Assaf Mizrahi, et al.
Scientific Reports|January 22, 2026
Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric studyCharlène Lefèvre, Théo Funck-Brentano, Marine Cachanado, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annales De Biologie Clinique|November 16, 2021
A typical babesiosis in an immunocompetent patientOlivier Voisin, Lorra Monpierre, Erwan Le Lorc'h, et al.
Mayo Clinic Proceedings|August 6, 2020
Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 InfectionOlivier Voisin, Erwan le Lorc'h, Annabelle Mahé, et al.
Infectious Diseases in Clinical Practice (Baltimore, Md.)|June 30, 2021
Disseminated Herpes Zoster During COVID-19Olivier Voisin, Nina Deluca, Annabelle Mahé, et al.
The Lancet. Rheumatology|August 25, 2020
Anakinra for severe forms of COVID-19: a cohort studyThomas Huet, Hélène Beaussier, Olivier Voisin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 16, 2021
No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot studyBenoît Pilmis, Olivier Jiang, Assaf Mizrahi, et al.
Scientific Reports|January 22, 2026
Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric studyCharlène Lefèvre, Théo Funck-Brentano, Marine Cachanado, et al.
Pageof 1